WOODMONT INVESTMENT COUNSEL LLC - BIOCRYST PHARMACEUTICALS INC ownership

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 106 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 1.31 and the average weighting 0.3%.

Quarter-by-quarter ownership
WOODMONT INVESTMENT COUNSEL LLC ownership history of BIOCRYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2016$9,000
+50.0%
2,1150.0%0.00%
+50.0%
Q1 2016$6,000
-72.7%
2,1150.0%0.00%
-66.7%
Q4 2015$22,000
-8.3%
2,1150.0%0.01%
-14.3%
Q3 2015$24,000
-62.5%
2,115
-50.0%
0.01%
-30.0%
Q2 2015$64,0004,2300.01%
Other shareholders
BIOCRYST PHARMACEUTICALS INC shareholders Q3 2016
NameSharesValueWeighting ↓
Sarissa Capital Management LP 3,926,700$56,427,0004.43%
ORACLE INVESTMENT MANAGEMENT INC 1,920,733$27,601,0003.44%
HealthCor Management, L.P. 3,849,470$55,317,0002.39%
MPM BioImpact LLC 704,767$10,128,0001.57%
Baker Brothers Advisors 12,710,818$182,654,0000.80%
Bain Capital Public Equity Management II, LLC 1,472,471$21,159,0000.74%
Biondo Investment Advisors, LLC 267,480$3,844,0000.66%
North Star Investment Management Corp. 442,900$6,364,0000.52%
DOLIVER ADVISORS, LP 100,000$1,437,0000.48%
Lisanti Capital Growth, LLC 219,450$3,153,0000.46%
View complete list of BIOCRYST PHARMACEUTICALS INC shareholders